The impact of preradiation residual disease volume on time to locoregional failure in cutaneous merkel cell carcinoma - A TROG substudy

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 91-95

  Finnigan, Renee ^a   Hruby, George ^b   Wratten, Chris ^c   Keller, Jacqui ^d   Tripcony, Lee ^d   Dickie, Graeme ^d   Rischin, Danny ^e   Poulsen, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIATION THERAPIES; CONFIDENCE INTERVAL; DISEASE-SPECIFIC SURVIVAL RATES; MARGIN STATUS; MERKEL CELL CARCINOMA; METHODS AND MATERIALS; RESIDUAL DISEASE; STATISTICALLY SIGNIFICANT DIFFERENCE;

CHEMOTHERAPY; PATIENT MONITORING; PATIENT TREATMENT;

DISEASE CONTROL;

CARBOPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER THERAPY; CHEMORADIOTHERAPY; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; DISTANT FAILURE FREE SURVIVAL; FEMALE; HAZARD RATIO; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; MICROSCOPY; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, MERKEL CELL; CHEMORADIOTHERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ETOPOSIDE; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT FAILURE;

EID: 84876112631     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.11.026     Document Type: Article

References (20)

1. N.C. Hodgson Merkel cell carcinoma: changing incidence trends J Surg Oncol 89 2005 1 4 (Pubitemid 40075960)
2. H. Feng, M. Shuda, and Y. Chang Clonal integration of Polyomavirus in human Merkel cell carcinoma Science 319 2008 1096 1099
3. P.J. Allen, W.B. Bowne, and D.P. Jaques Merkel cell carcinoma: Prognosis and treatment from a single institution J Clin Oncol 23 2005 2300 2309 (Pubitemid 46218722)
4. P. Mojica, D. Smith, and J.D.I. Ellenhorn Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin J Clin Oncol 25 2007 1043 1047 (Pubitemid 46596754)
5. M. Ghaderi, J. Coury, and J. Oxenberg Primary Merkel cell carcinoma of the parotid gland Ear Nose Throat J 89 2010 E24 E27
6. K.G. Lewis, M.A. Weinstock, and A.L. Weaver Adjuvant local irradiation for Merkel cell carcinoma Arch Dermatol 142 2006 693 700
7. T. Jouary, C. Leyral, and B. Dreno Adjuvant prophylactic regional radiotherapy versus observation in stage 1 Merkel cell carcinoma: A multicentric prospective randomised study Ann Oncol 23 2012 1074 1080
8. M. Veness Improved outcome with the addition of adjuvant therapy J Clin Oncol 25 2005 7235 7237
9. M. Poulsen, D. Rischin, and E. Walpole High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group Study - TROG 96:07 J Clin Oncol 21 2003 4371 4376 (Pubitemid 46621814)
10. M. Poulsen, and J. Harvey Is there a diminishing role for surgery in Merkel cell carcinoma of the skin? A review of the current management ANZ J Surg 72 2002 142 146 (Pubitemid 34175336)
11. M. Veness, M. Foote, and V. Gebski The role of radiotherapy alone in patients with merkel cell carcinoma: Reporting the Australian experience of 43 patients Int J Radiat Oncol Biol Phys 78 2010 703 709
12. A.C. Hui, A.L. Stillie, and M. Seel Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre Int J Radiat Oncol Biol Phys 80 2011 1430 1435
13. M. Poulsen, D. Rischin, and E. Walpole Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group study Int J Rad Oncology Biol Phys 51 2001 156 163 (Pubitemid 32758875)
14. M. Poulsen, E. Walpole, and J. Harvey Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin Int J Radiat Oncol Biol Phys 72 2008 1070 1074
15. D. Ratner Merkel cell carcinoma of the left temple Skin Med 3 2004 102 104
16. A.M. Gillenwater, A.C. Hessel, and W.H. Morrison Merkel cell carcinoma of the head and neck: Effect of surgical excision and radiation on recurrence and surivival Arch Otolaryngol Head Neck Surg 127 2001 149 154 (Pubitemid 32163640)
17. R.C. Fields, K.J. Busam, and J.F. Chou Five hundred patients with Merkel cell carcinoma evaluated at a single institution Ann Surg 254 2011 465 473 discussion 73-75
18. J. Meeuwissen, R. Bourne, and J. Kearsley The importance of postoperative radiotherapy in the treatment of Merkel cell carcinoma Int J Radiation Oncol Biol Phys 31 1995 325 331
19. P. Sundaresan, G. Hruby, and A. Hamilton Definitive radiotherapy or chemo-radiotherapy in the treatment of Merkel cell carcinoma Clin Oncol 24 2012 e131 e136
20. M. Foote, J. Harvey, and S. Porceddu Effect of radiotherapy dose and volume of relapse in Merkel cell cancer of the skin Int J Radiat Oncol Biol Phys 77 2010 677 684